Cargando…
REDD1 is a determinant of low-dose metronomic doxorubicin-elicited endothelial cell dysfunction through downregulation of VEGFR-2/3 expression
Low-dose metronomic chemotherapy (LDMC) inhibits tumor angiogenesis and growth by targeting tumor-associated endothelial cells, but the molecular mechanism has not been fully elucidated. Here, we examined the functional role of regulated in development and DNA damage responses 1 (REDD1), an inhibito...
Autores principales: | Park, Minsik, Kim, Joohwan, Kim, Taesam, Kim, Suji, Park, Wonjin, Ha, Kwon-Soo, Cho, Sung Hwan, Won, Moo-Ho, Lee, Jeong-Hyung, Kwon, Young-Guen, Kim, Young-Myeong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8568908/ https://www.ncbi.nlm.nih.gov/pubmed/34697389 http://dx.doi.org/10.1038/s12276-021-00690-z |
Ejemplares similares
-
Low-dose metronomic doxorubicin inhibits mobilization and differentiation of endothelial progenitor cells through REDD1-mediated VEGFR-2 downregulation
por: Park, Minsik, et al.
Publicado: (2021) -
REDD1 promotes obesity-induced metabolic dysfunction via atypical NF-κB activation
por: Lee, Dong-Keon, et al.
Publicado: (2022) -
NF-κB-responsive miR-155 induces functional impairment of vascular smooth muscle cells by downregulating soluble guanylyl cyclase
por: Park, Minsik, et al.
Publicado: (2019) -
NF-κB-dependent miR-31/155 biogenesis is essential for TNF-α-induced impairment of endothelial progenitor cell function
por: Kim, Ji-Hee, et al.
Publicado: (2020) -
Arg-Leu-Tyr-Glu Suppresses Retinal Endothelial Permeability and Choroidal Neovascularization by Inhibiting the VEGF Receptor 2 Signaling Pathway
por: Park, Wonjin, et al.
Publicado: (2019)